THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES

The Registry pretends to identify stratification, diagnosis and treatment approaches in patients with Acute Coronary Syndrome (ACS) in community hospitals with tertiary hospitals to optimize resources and identify strategies to improve health care quality through the creation of clinical guidelines that serve for unify management and treatment methods with adherence to international guidelines which include suggestions for treatment and medication.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndromes Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients with suspected ACS and will analyze risk factors, chest pain and electrocardiographic characteristics.

Exclusion criteria

Patients with secondary ischemia (anaemia, pulmonary thromboembolism, myocarditis) and type II infarction.

Treatment and study plan

Primary outcomes

Number of patients with complications after presenting ACS

Time frame: up to one year

The main objective will be to know the evolution of ACS in third and second level hospitals with a monitoring at a minimum of one year for each patient.

Sponsors and collaborators

Lead sponsor

Third National Registry of Acute Coronary Syndromes

Other

Registry information

Acronym: RENASICA_III

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: May 19, 2014
Registry last updated: May 19, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed